Ceftazidime as single-agent therapy for gram-negative aerobic bacillary osteomyelitis.
The cases of 28 patients who received ceftazidime as single-agent therapy in prospective clinical trials for biopsy culture-proven osteomyelitis were reviewed. These cases all involved infection caused by gram-negative aerobic bacilli, the most frequent agent (83% of patients) being Pseudomonas aeru...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1987
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174999/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3124734/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.10.1605 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|